16 results on '"Oshima, Junko"'
Search Results
2. Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions.
- Author
-
Oshima, Junko, Sidorova, Julia M., and Jr.Monnat, Raymond J.
- Subjects
- *
PREMATURE aging (Medicine) , *WERNER'S syndrome , *DNA helicases , *DNA repair , *DNA replication , *GENETIC mutation - Abstract
Werner syndrome (WS) is a prototypical segmental progeroid syndrome characterized by multiple features consistent with accelerated aging. It is caused by null mutations of the WRN gene, which encodes a member of the RECQ family of DNA helicases. A unique feature of the WRN helicase is the presence of an exonuclease domain in its N-terminal region. Biochemical and cell biological studies during the past decade have demonstrated involvements of the WRN protein in multiple DNA transactions, including DNA repair, recombination, replication and transcription. A role of the WRN protein in telomere maintenance could explain many of the WS phenotypes. Recent discoveries of new progeroid loci found in atypical Werner cases continue to support the concept of genomic instability as a major mechanism of biological aging. Based on these biological insights, efforts are underway to develop therapeutic interventions for WS and related progeroid syndromes. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Search and Insights into Novel Genetic Alterations Leading to Classical and Atypical Werner Syndrome.
- Author
-
Oshima, Junko and Hisama, Fuki M.
- Subjects
- *
WERNER'S syndrome , *PREMATURE aging (Medicine) , *GENETIC disorders , *MEDICAL genetics , *GENETIC mutation , *GENETICS - Abstract
Segmental progeroid syndromes are a group of disorders with multiple features resembling accelerated aging. Adult-onset Werner syndrome (WS) and childhood-onset Hutchinson-Gilford progeria syndrome are the best known examples. The discovery of genes responsible for such syndromes has facilitated our understanding of the basic mechanisms of aging as well as the pathogenesis of other common, age-related diseases. Our International Registry of Werner Syndrome accesses progeroid pedigrees from all over the world, including those for whom we have ruled out a mutation at the WRN locus. Cases without WRN mutations are operationally categorized as 'atypical WS' (AWS). In 2003, we identified LMNA mutations among a subset of AWS cases using a candidate gene approach. As of 2013, the Registry has 142 WS patients with WRN mutations, 11 AWS patients with LMNA mutations, and 49 AWS patients that have neither WRN nor LMNA mutations. Efforts are underway to identify the responsible genes for AWS with unknown genetic causes. While WS and AWS are rare disorders, the causative genes have been shown to have much wider implications for cancer, cardiovascular disease and the biology of aging. Remarkably, centenarian studies revealed WRN and LMNA polymorphic variants among those who have escaped various geriatric disorders. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.
- Author
-
Muftuoglu, Meltem, Oshima, Junko, von Kobbe, Cayetano, Wen-Hsing Cheng, Leistritz, Dru F., and Bohr, Vilhelm A.
- Subjects
- *
WERNER'S syndrome , *PROGERIA , *DNA repair , *DEVELOPMENTAL biology , *NUCLEOTIDE sequence - Abstract
Werner syndrome (WS) is an adult onset segmental progeroid syndrome caused by mutations in the WRN gene. The WRN gene encodes a 180 kDa nuclear protein that possesses helicase and exonuclease activities. The absence of WRN protein leads to abnormalities in various DNA metabolic pathways such as DNA repair, replication and telomere maintenance. Individuals with WS generally develop normally until the third decade of life, when premature aging phenotypes and a series of age-related disorders begin to manifest. In Japan, where a founder effect has been described, the frequency of Werner heterozygotes appears to be as high as 1/180 in the general population. Due to the relatively non-specific nature of the symptoms and the lack of awareness of the condition, this disease may be under-diagnosed in other parts of the world. Genetic counseling of WS patients follows the path of other autosomal recessive disorders, with special attention needed for cancer surveillance in relatives. Molecular diagnosis of WS is made by nucleotide sequencing and, in some cases, protein analysis. It is also of potential interest to measure WRN activities in WS patients. More than 50 different disease-causing mutations in the WRN gene have been identified in WS patients from all over the world. All but one of these cases has mutations that result in the premature termination of the protein. Here we describe the clinical, molecular and biochemical characteristics of WS for use by medical professionals in a health care setting. Additional information is available through the International Registry of WS (). [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
5. Accumulation of Werner protein at DNA double-strand breaks in human cells.
- Author
-
Li Lan, Nakajima, Satoshi, Komatsu, Kenshi, Nussenzweig, Andre, Shimamoto, Akira, Oshima, Junko, and Yasui, Akira
- Subjects
WERNER'S syndrome ,DEVELOPMENTAL biology ,DNA damage ,BIOCHEMICAL genetics ,PROTEIN kinases ,EXONUCLEASES - Abstract
Werner syndrome is an autosomal recessive accelerated-aging disorder caused by a defect in the WRN gene, which encodes a member of the RecQ family of DNA helicases with an exonuclease activity. In vitro experiments have suggested that WRN functions in several DNA repair processes, but the actual functions of WRN in living cells remain unknown. Here, we analyzed the kinetics of the intra nuclear mobilization of WRN protein in response to a variety of types of DNA damage produced locally in the nucleus of human cells. A striking accumulation of WRN was observed at laser-induced double-strand breaks, but not at single-strand breaks or oxidative base damage. The accumulation of WRN at double-strand breaks was rapid, persisted for many hours, and occurred in the absence of several known interacting proteins including polymerase α, poly(ADP-ribose) polymerase 1 (PARP1), Ku 80, DNA-dependent protein kinase (DNA-PKcs), NBS1 and histone H2AX. Abolition of helicase activity or deletion of the exonuclease domain had no effect on accumulation, whereas the presence of the HRDC (helicase and RNaseD C-terminal) domain was necessary and sufficient for the accumulation. Our data suggest that WRN functions mainly at DNA double-strand breaks and structures resembling double-strand breaks in living cells, and that an autonomous accumulation through the HRDC domain is the initial response of WRN to the double-strand breaks. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
6. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair.
- Author
-
Chen, Lishan, Huang, Shurong, Lee, Lin, Davalos, Albert, Schiestl, Robert H., Campisi, Judith, and Oshima, Junko
- Subjects
WERNER'S syndrome ,SYNDROMES ,DNA repair ,BIOCHEMICAL genetics ,ANTIMUTAGENS ,AGING - Abstract
Summary Werner syndrome (WS) predisposes patients to cancer and premature aging, owing to mutations in WRN . The WRN protein is a RECQ-like helicase and is thought to participate in DNA double-strand break (DSB) repair by non-homologous end joining (NHEJ) or homologous recombination (HR). It has been previously shown that non-homologous DNA ends develop extensive deletions during repair in WS cells, and that this WS phenotype was complemented by wild-type (wt) WRN. WRN possesses both 3′ → 5′ exonuclease and 3′ → 5′ helicase activities. To determine the relative contributions of each of these distinct enzymatic activities to DSB repair, we examined NHEJ and HR in WS cells (WRN–/–) complemented with either wtWRN, exonuclease-defective WRN (E–), helicase-defective WRN (H–) or exonuclease/helicase-defective WRN (E–H–). The single E– and H– mutants each partially complemented the NHEJ abnormality of WRN–/– cells. Strikingly, the E–H– double mutant complemented the WS deficiency nearly as efficiently as did wtWRN. Similarly, the double mutant complemented the moderate HR deficiency of WS cells nearly as well as did wtWRN, whereas the E– and H– single mutants increased HR to levels higher than those restored by either E–H– or wtWRN. These results suggest that balanced exonuclease and helicase activities of WRN are required for optimal HR. Moreover, WRN appears to play a structural role, independent of its enzymatic activities, in optimizing HR and efficient NHEJ repair. Another human RECQ helicase, BLM, suppressed HR but had little or no effect on NHEJ, suggesting that mammalian RECQ helicases have distinct functions that can finely regulate recombination events. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
7. Lessons from human progeroid syndromes.
- Author
-
Martin, George M. and Oshima, Junko
- Subjects
- *
AGING , *GENETIC mutation , *WERNER'S syndrome , *GENES , *GENETICS - Abstract
Reports that a number of human genes have been identified in which mutations can lead to the acceleration of aging. How studies of these genes and their protein products may lead to a clearer understanding of aging; Mention of age-related diseases, including Alzheimer's disease; Explanation of Werner syndrome, which leads to symptoms such as cataracts, osteoporosis and atherosclerosis; Opinion that senescence results from the waning of the force of natural selection.
- Published
- 2000
- Full Text
- View/download PDF
8. The Werner syndrome protein: an update.
- Author
-
Oshima, Junko
- Subjects
- *
WERNER'S syndrome , *PROTEINS , *AGING , *SYNDROMES - Abstract
Discusses the progress in the understanding of the WRN protein and its implication in the normal aging process. Clinical characteristics of Werner syndrome; Components of Werner syndrome gene product; Biology of WRN and postulated cellular functions of the WRN protein.
- Published
- 2000
- Full Text
- View/download PDF
9. Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.
- Author
-
Saha, Bidisha, Cypro, Alexander, Martin, George M., and Oshima, Junko
- Subjects
RAPAMYCIN ,DNA damage ,CELL growth ,FIBROBLASTS ,TARGETED drug delivery ,GENETIC mutation ,WERNER'S syndrome - Abstract
Werner syndrome (WS), caused by mutations at the WRN helicase gene, is a progeroid syndrome characterized by multiple features consistent with accelerated aging. Aberrant double-strand DNA damage repair leads to genomic instability and reduced replicative lifespan of somatic cells. We observed increased autophagy in WRN knockdown cells; this was further increased by short-term rapamycin treatment. Long-term rapamycin treatment resulted in improved growth rate, reduced accumulation of DNA damage foci and improved nuclear morphology; autophagy markers were reduced to near-normal levels, possibly due to clearance of damaged proteins. These data suggest that protein aggregation plays a role in the development of WS phenotypes and that the mammalian target of rapamycin complex 1 pathway is a potential therapeutic target of WS. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
10. Epigenetic signatures of Werner syndrome occur early in life and are distinct from normal epigenetic aging processes.
- Author
-
Maierhofer, Anna, Flunkert, Julia, Oshima, Junko, Martin, George M., Poot, Martin, Nanda, Indrajit, Dittrich, Marcus, Müller, Tobias, and Haaf, Thomas
- Subjects
WERNER'S syndrome ,PREMATURE aging (Medicine) ,DNA methylation ,TRANSCRIPTION factors ,METHYLATION - Abstract
Werner Syndrome (WS) is an adult‐onset segmental progeroid syndrome. Bisulfite pyrosequencing of repetitive DNA families revealed comparable blood DNA methylation levels between classical (18 WRN‐mutant) or atypical WS (3 LMNA‐mutant and 3 POLD1‐mutant) patients and age‐ and sex‐matched controls. WS was not associated with either age‐related accelerated global losses of ALU, LINE1, and α‐satellite DNA methylations or gains of rDNA methylation. Single CpG methylation was analyzed with Infinium MethylationEPIC arrays. In a correspondence analysis, atypical WS samples clustered together with the controls and were clearly separated from classical WS, consistent with distinct epigenetic pathologies. In classical WS, we identified 659 differentially methylated regions (DMRs) comprising 3,656 CpG sites and 613 RefSeq genes. The top DMR was located in the HOXA4 promoter. Additional DMR genes included LMNA, POLD1, and 132 genes which have been reported to be differentially expressed in WRN‐mutant/depleted cells. DMRs were enriched in genes with molecular functions linked to transcription factor activity and sequence‐specific DNA binding to promoters transcribed by RNA polymerase II. We propose that transcriptional misregulation of downstream genes by the absence of WRN protein contributes to the variable premature aging phenotypes of WS. There were no CpG sites showing significant differences in DNA methylation changes with age between WS patients and controls. Genes with both WS‐ and age‐related methylation changes exhibited a constant offset of methylation between WRN‐mutant patients and controls across the entire analyzed age range. WS‐specific epigenetic signatures occur early in life and do not simply reflect an acceleration of normal epigenetic aging processes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease.
- Author
-
Huang, Shurong, Li, Baomin, Gray, Matthew D., Oshima, Junko, Mian, I. Saira, and Campisi, Judith
- Subjects
WERNER'S syndrome ,EXONUCLEASES ,ENDONUCLEASES ,GENETICS - Abstract
Tests the prediction that WRN, the gene defective in Werner syndrome, is an exonuclease. Use of tagged recombinant wild-type and mutant WRN proteins; Finding that WRN is indeed an endonuclease, which resides in the N terminus; Difference from other human RecQ-like helicases; Possible explanation for the differences between Werner syndrome and Bloom's syndrome.
- Published
- 1998
- Full Text
- View/download PDF
12. Clinical utility gene card for: Werner Syndrome - Update 2014.
- Author
-
Hisama, Fuki M, Kubisch, Christian, Martin, George M, and Oshima, Junko
- Subjects
WERNER'S syndrome ,GENETIC disorder diagnosis ,PROGERIA ,PREMATURE aging (Medicine) ,EXONS (Genetics) ,GENETICS ,DIAGNOSIS - Abstract
The article presents a study which examines a clinical utility gene card for the diagnosis of Werner disease. Topics of the study include the analysis of mutations of exon as well as genomic rearrangement, the validation of assessing for nucleotide and proteins sequencing and the estimated frequency of the disease. The diagnostic features of Werner's syndrome disease are also presented.
- Published
- 2015
- Full Text
- View/download PDF
13. Clinical utility gene card for: Werner syndrome.
- Author
-
Hisama, Fuki M, Kubisch, Christian, Martin, George M, and Oshima, Junko
- Subjects
WERNER'S syndrome ,GENETIC testing ,PREMATURE aging (Medicine) ,DIABETES ,GENETIC disorder diagnosis - Abstract
The article offers information on genetic testing for the diagnosis of Werner syndrome, an adult-onset disorder. It informs that the earliest symptom is the lack of a growth spurt in adolescence. It reports that gene testing can be vital in patients for confirming the autosomal recessive inheritance. Werner syndrome can also be diagnosed clinically in many ways including testing for diabetes mellitus and taking a family pedigree.
- Published
- 2012
- Full Text
- View/download PDF
14. Functional deficit associated with a missense Werner syndrome mutation.
- Author
-
Tadokoro, Takashi, Rybanska-Spaeder, Ivana, Kulikowicz, Tomasz, Dawut, Lale, Oshima, Junko, Croteau, Deborah L., and Bohr, Vilhelm A.
- Subjects
- *
WERNER'S syndrome , *MISSENSE mutation , *EXONUCLEASES , *DNA helicases , *ADENOSINE triphosphate , *PROTEIN binding - Abstract
Highlights: [•] WRN G574R exhibits significantly decreased helicase activity. [•] G574R displays decreased exonuclease and increased strand annealing activities. [•] The loss of the helicase activity of G574R is due to the lack of ATP binding. [•] The Werner syndrome patient carrying G574R has normal stature, and this is unusual. [•] The short stature normally associated with WS may not be due to helicase deficiency. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
15. LMNA mutations in atypical Werner's syndrome.
- Author
-
Chen, Lishan, Lee, Lin, Kudlow, Brian A., Dos Santos, Heloisa G., Sletvold, Olav, Shafeghati, Yousef, Botha, Eleanor G., Garg, Abhimanyu, Hanson, Nancy B., Martin, George M., Mian, I. Saira, Kennedy, Brian K., and Oshima, Junko
- Subjects
- *
WERNER'S syndrome , *SYNDROMES , *PROGERIA , *GENETIC mutation , *DISEASES - Abstract
Background Werner's syndrome is a progeroid syndrome caused by mutations at the WRN helicase locus. Some features of this disorder are also present in laminopathies caused by mutant LMNA encoding nuclear lamin A/C. Because of this similarity, we sequenced LMNA in individuals with atypical Werner's syndrome (wild-type WRN). Methods Of 129 index patients referred to our international registry for molecular diagnosis of Werner's syndrome, 26 (20%) had wildtype WRN coding regions and were categorised as having atypical Werner's syndrome on the basis of molecular criteria. We sequenced all exons of LMNA in these individuals. Mutations were confirmed at the mRNA level by RT-PCR sequencing. In one patient in whom an LMNA mutation was detected and fibroblasts were available, we established nuclear morphology and subnuclear localisation. Findings In four (15%) of 26 patients with atypical Werner's syndrome, we noted heterozygosity for novel missense mutations in LMNA, specifically A57P, R133L (in two people), and L140R. The mutations altered relatively conserved residues within lamin A/C. Fibroblasts from the patient with the L140R mutation had a substantially enhanced proportion of nuclei with altered morphology and mislocalised lamins. Individuals with atypical Werner's syndrome with mutations in LMNA had a more severe phenotype than did those with the disorder due to mutant WRN. Interpretation Our findings indicate that Werner's syndrome is molecularly heterogeneous, and a subset of the disorder can be judged a laminopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
16. Werner syndrome protein limits MYC-induced cellular senescene.
- Author
-
Grandori, Carla, Wu, Kou-Juey, Fernandez, Paula, Ngoouenet, Celine, Grim, Jonathan, Clurman, Bruce E., Moser, Michael J., Oshima, Junko, Russell, David W., Swisshelm, Karen, Frank, Scott, Amati, Bruno, Dalla-Favera, Riccardo, and Monnat Jr., Raymond J.
- Subjects
- *
WERNER'S syndrome , *PROGERIA , *MYC proteins , *TUMOR proteins , *TRANSCRIPTION factors , *CELLULAR aging - Abstract
Presents a study which proposed that the human Werner syndrome gene up-regulation by the MYC oncoprotein may promote MYC-driven tumorgenesis by preventing cellular senescence. Description of the MYC oncoprotein; Capabilities of MYC overexpression; Cause of the occurrence of rapid cellular senescence.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.